Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which…
Vinge has advised Röko AB (publ) (“Röko”) in connection with its listing on Nasdaq Stockholm. The pr…
Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue…
Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby…
Vinge has advised SmartCella Holding AB in connection with its fund raising of EUR 50 million. The c…
Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which wi…
Vinge has advised Re:NewCell, a textile-to-textile recycling company listed on Nasdaq First North Pr…
Vinge has advised Vicore Pharma Holding AB (publ) in connection with directed share issuances, where…
Vinge has adviced VNV Global in connection with its fully secured rights issue of approximately SEK…
Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby…
Vinge has advised Mentimeter AB (publ) in connection with a private placement of approximately SEK 4…
Vinge has advised Bring in conjunction with its investment in the logtech company DreamLogistics, wh…
Vinge has advised Fidelio Capital AB in its majority investment in Hemfrid i Sverige AB, the leading…
Vinge has acted as Swedish legal advisor to EQT Private Equity and PRO Unlimited in connection with…
Vinge is advising Vimian and the principal shareholder Fidelio in connection with a private placemen…
Vinge advises Ottobock, a portfolio company to EQT, on its acquisition of Exoneural Network AB a Swe…
